Eli Lilly has thrown its weight behind a cause beyond the traditional remit of pharma companies. | Eli Lilly has thrown its ...
Unfortunately, many of our elected leaders today undervalue the role of patents to progress the science of drug discovery and ...
U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a ...
GlobalData on MSN22h
Eli Lilly will ‘build new way of doing science’ in UK amid £297m pledge to governmentEli Lilly’s senior VP of information and R&D IT, Ramesh Durvasula, said Lilly will use AI and tech to transform the company.
Despite this, investors seem to have made up their one-track mind. Eli Lilly’s P/E ratio is more than double that of Novo ...
Eli Lilly (LLY) partners with British government for a first-of-its-kind real-world study on economic effects of its weight ...
Eli Lilly's valuation could look much more modest in the future, as its earnings should continue to grow at a high rate.
In win for compounders, FDA will review its decision to put Eli Lilly's tirzepatide on shortage list
In accepting the FDA’s motion, U.S. District Judge Mark Pittman put on hold a lawsuit filed by the Outsourcing Facilities ...
DBS analyst Nico Chen has maintained their bullish stance on LLY stock, giving a Buy rating yesterday. Nico Chen has given his Buy rating due ...
The U.K. will study whether Lilly's weight loss drug can get people back to work and help tackle long-term sickness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback